Teva Pharmaceuticals
TEVA
TEVA
539 hedge funds and large institutions have $16.2B invested in Teva Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 87 funds opening new positions, 177 increasing their positions, 160 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
539
Holders Change
+33
Holders Change %
+6.52%
% of All Funds
12.36%
Holding in Top 10
16
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+60%
% of All Funds
0.37%
New
87
Increased
177
Reduced
160
Closed
48
Calls
$614M
Puts
$765M
Net Calls
-$151M
Net Calls Change
+$60.4M
Top Buyers
| 1 |
PC
PointState Capital
New York
|
+$162M |
| 2 |
Millennium Management
New York
|
+$135M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$100M |
| 4 |
Citigroup
New York
|
+$97M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$90.7M |
